J9303 Panitumumab - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Panitumumab

Brand Name:

Vectibix

Strength:

10mg

HCPCS:

J9303

SEER*Rx Category:

Immunotherapy

Major Drug Class:

Monoclonal Antibody

Minor Drug Class:

EGFR

Oral (Y/N):

No

FDA Approval Year:

2006

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2008

CMS Discontinuation Date:

Status:

In Use